Pfizer (PFE) Assets Average (2009 - 2026)

Pfizer (PFE) has 18 years of Assets Average data on file, last reported at $208.1 billion in Q1 2026.

• Quarterly Assets Average fell 1.25% year-over-year to $208.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $208.1 billion (down 1.25% YoY) and the FY2025 annual result came in at $210.8 billion, down 2.61% from the prior year.
• Assets Average steadied at $208.1 billion in Q1 2026 per PFE's latest filing, from $208.6 billion in the prior quarter.
• Across five years, Assets Average topped out at $223.8 billion in Q1 2024 and bottomed at $118.2 billion in Q4 2022.
• The 5-year median for Assets Average is $208.1 billion (2026), against an average of $198.3 billion.
• The widest annual swing landed in 2023, when Assets Average surged 85.4%; it then retreated 5.85% in 2025.
• Tracing PFE's Assets Average over 5 years: stood at $119.1 billion in 2022, then surged by 85.4% to $220.8 billion in 2023, then declined by 1.95% to $216.4 billion in 2024, then fell by 3.63% to $208.6 billion in 2025, then fell by 0.24% to $208.1 billion in 2026.
• Per Business Quant, the three latest PFE Assets Average figures stand at $208.1 billion (Q1 2026), $208.6 billion (Q4 2025), and $207.5 billion (Q3 2025).

Peer Comparison